RB1 and breast carcinoma: The clinical relevance of this gene is further supported by the evidence that mutations in BRIP1 confer an increased risk of breast cancer and transcription of BRIP1 has been found to be cell growth-related and controlled by the E2F/retinoblastoma (Rb) pathway through a conserved E2F-responsive site29.